In renal cell carcinoma patients on sunitinib, separation of ILD or DAH from pulmonary metastatic disease can be exceedingly difficult (PMID 19289369)

Last update : 15/10/2014
I - Interstitial/parenchymal lung disease
II - Pulmonary edema - Acute lung injury - ARDS
III - Pulmonary/alveolar hemorrhage
V - Pleural and/or pericardial involvement
VI - Pulmonary vasculopathies
XII - Cardiovascular involvement / toxicity
XVI - Imaging